Skip to content

NKTRNEKTAR THERAPEUTICS

CUSIP 640268306 · common stock

2 tracked investors held NEKTAR THERAPEUTICS (NKTR) at the end of Q3 2026, worth $32.1M in total. The largest holder was PRIMECAP Management, with 0.0% of its portfolio.

Holders · Q3 2026
2
New holders
0
Value held
$32.1M
Quarter-end price (est.)
$60.54

Investors holding NKTR · Q3 2026

InvestorWeightSharesValueChange
PRIMECAP Management
PRIMECAP Management Co
0.01%272,390$16.5MREDUCE-0.2%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.67%258,182$15.6MADD+5.7%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026200$32.1M$60.54
Q2 2026200$36.1M$69.81
Q1 2026200$31.7M$71.95
Q4 2025200$14.9M$42.28